Biotech-IgG AB expands product range by membership in DiaMondiaL

Biotech-IgG AB (publ) has today been admitted as member of the European In Vitro Diagnostics (IVD) grouping DiaMondiaL. Membership means that Biotech-IgG AB receives the right to exclusively represent and distribute DiaMondiaLs products on the Swedish, Danish, Finnish and Norwegian markets.


DiaMondiaL (www.diamondial.com) is a European Economic Interest Grouping (EEIG), which facilitates and develops business opportunities for its members through the provision and creation of common resources, activities and expertise. DiaMondiaL has through its 10 members a wide cooperation in the IVD field and also works as a producer and distributor of several own IVD products. The member companies have the exclusive right to sell these products in their respective markets. The DiaMondiaL member companies have a combined sales of over 300 million Euros, together employ over 1,000 people and is represented in over 30 European countries.


Associate Professor Dario Kriz

President and Group CEO


Biotech-IgG AB (publ), Odarslövsvägen 50, SE-225 92 LUND,

tel +46-(0)46-12 37 40, fax +46-(0)46-12 37 60,

Internet: www.biotech-igg.com, mail: info@biotech-igg.com.

Contact person: Associate Professor Dario Kriz, President

Chairman: Dr Margareta Krook


Biotech-IgG is a supplier of a wide range of quality products for medical diagnostics and research, routine and process applications for the life science and food industries. Biotech-IgG group's vision is to become the leading Scandinavian distributor of immune diagnostics and life science products to the healthcare industry and that also offers a full line of proprietary products for a well-defined group of customers operating in the production, development and analysis of proteins, especially antibodies.

Back to news